Toggle navigation
CERSI
Excipients
Home
Molecular
Oral
Unresolved
Rarely Used
Products
APIs
Lidocaine
Product manufactured by
Direct Rx
Application Nr
Approved Date
Route
Status
External Links
NDA020612
None
Cutaneous
None
Google
,
Wikipedia
,
PubMed
,
DailyMed
,
Raw OpenFDA
,
ECHA
,
ToxNet
,
JECFA
,
FAO
,
21 CFR
Indications and Purposes
Lidocaine Patch 5% Is Indicated For Relief Of Pain Associated With Post-Herpetic Neuralgia. It Should Be Applied Only To Intact Skin.
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name
Structure
ZINC ID(s)
1.
Lidocaine
ZINC20237
Comments
Please enable JavaScript to view the
comments powered by Disqus.